Pharmaceutical Preparation Manufacturing
Madrigal Pharmaceuticals Inc
% of Portfolio
26.6%
Average Buy Price
$225.10
+109.4%
Current Price
$471.32
Q1 2026
Sold 18.5% shares
26.6% of Portfolio
Sold 18.5% in Q1 2026
Avg closing price
Price range
See more trades by signing up for free
Google
Facebook
Or continue with email
View all investments of John Paulson
